SciSparc Ltd. logo

SciSparc Ltd. (SPRC)

Market Closed
8 Dec, 20:00
NASDAQ (CM) NASDAQ (CM)
$
2. 01
+0.27
+15.52%
After Hours
$
2. 02
+0.01 +0.5%
1.14M Market Cap
- P/E Ratio
0% Div Yield
1,133,796 Volume
0 Eps
$ 1.74
Previous Close
Day Range
1.76 2.05
Year Range
1.55 37.59
Want to track SPRC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Is Psychedelic-SciSparc Stock Trading Higher On Monday?

Why Is Psychedelic-SciSparc Stock Trading Higher On Monday?

On Monday, SciSparc Ltd SPRC stock is trading higher with a session volume of 30.86 million compared to an average volume of 7.73 million as per data from Benzinga Pro.

Benzinga | 11 months ago
S&P 500 Edges Lower, SciSparc Shares Surge

S&P 500 Edges Lower, SciSparc Shares Surge

U.S. stocks traded slightly lower toward the end of trading, with the S&P 500 edging lower on Thursday.

Benzinga | 11 months ago
Israeli Penny Stock Biotech SciSparc Outlicenses Its Cannabinoid Pain Therapy

Israeli Penny Stock Biotech SciSparc Outlicenses Its Cannabinoid Pain Therapy

Friday, SciSparc Ltd. SPRC signed an exclusive patent license agreement with Polyrizon Ltd to out-license its SCI-160 program to treat pain.

Benzinga | 1 year ago
Why Is SciSparc (SPRC) Stock Up 94% Today?

Why Is SciSparc (SPRC) Stock Up 94% Today?

SciSparc (NASDAQ: SPRC ) stock is on the rise Thursday after the clinical-stage pharmaceutical company provided investors with an update concerning its AutoMax Motors merger. The big news here is The Jerusalem District Court in Israel approving AutoMax's petition to convene special class meetings of shareholders to approve the SciSparc merger.

Investorplace | 1 year ago
Why Is SciSparc (SPRC) Stock Up 25% Today?

Why Is SciSparc (SPRC) Stock Up 25% Today?

SciSparc (NASDAQ: SPRC ) stock is up on Tuesday after the clinical-stage pharmaceutical company announced a new patent application covering its weight loss treatment. SciSparc notes that this patent covers the company's collaboration with Clearmind Medicine (NASDAQ: CMND ).

Investorplace | 1 year ago